Healthcare Triangle Inc. (NASDAQ: HCTI) announced that its board of directors approved a share repurchase program authorizing the company to buy back up to $2 million of its outstanding common stock. The board approved the 2026 Share Repurchase Plan on March 9, 2026, and it became effective immediately.

Under the program, the company may repurchase shares through open market transactions, privately negotiated transactions, or other methods in accordance with securities laws and regulations. The repurchases may be conducted under Rule 10b-18 of the Securities Exchange Act of 1934 and Rule 10b5-1 trading plans.

The timing, volume, and nature of repurchases will be determined by management based on market conditions, the trading price of the company's common stock, corporate liquidity requirements, legal requirements, and other factors. The program does not obligate the company to acquire any specific amount of shares and may be suspended, modified, or discontinued at any time.

"The approval of this share repurchase program reflects the Board's commitment to prudent capital allocation and its confidence in the Company's long-term strategy," said David Ayanoglou, chief financial officer of Healthcare Triangle Inc. "The program provides the Company with flexibility to opportunistically repurchase shares while continuing to support our operational and strategic priorities."

Any repurchased shares may be held as treasury stock or retired. The company may fund repurchases using available cash and cash equivalents or other sources of liquidity. The board also authorized company officers to take necessary actions to implement the plan, including engaging brokers and making required SEC filings.

Healthcare Triangle, based in Pleasanton, California, provides digital transformation solutions including managed services, cloud enablement, and data analytics for healthcare and life sciences industries.